All material subject to strictly enforced copyright laws. © 2022 Managing IP is part of the Euromoney Institutional Investor PLC group.

Life Sciences





The claim, filed at the England and Wales High Court, follows lawsuits launched by Moderna in the US and Germany
Novartis’s planned SCOTUS appeal may be a long shot, but the case raises interesting Section 112 and procedural questions, say counsel
A new report on brain-scanning technology and the law highlights why firms must value more than just productivity
The EU’s landmark SPC waiver has taken full effect, but generics still have plenty of legal obstacles to navigate
In-house panellists weighed up the most disruptive trends in IP, from the TRIPS waiver to the rise of remote working
Pharma counsel can look at suspicious packaging, online sellers and other signs to learn whether products are fake, say sources at Merck, Gilead and Organon
With the UPC almost here, pharma and biotech counsel are weighing the risks and rewards of the new system
UK Court of Appeal overturns Amazon judgment; GM takes Avanci patent licence; vaccine waiver draft released; IBM sues games maker
Counsel say Indian generic companies are starting to innovate and file invention patents but that they must scale up these activities to avoid becoming obsolete
Speakers at 3M, Mastercard and Merck revealed how they fought bad actors during a rise in fakes
Sources set out what different requirements for use and description and cancellation proceedings mean for their EU and US strategies
Russia has released a list of goods and trademarks that can be imported without permission, naming brands such as Apple, IBM and Samsung
Sponsored

Sponsored

Counsel at Blaze Bioscience, a generics drug company and three firms debate the effects of more examination time and attacks on incremental and obvious patents
Generics are sizing up new opportunities as UK courts get tough on preliminary injunctions, but an at-risk launch may still be too far
Deepa K Tiku and Juhi Sakrikar of K&S Partners analyse the latest trends in cannabis patent filings around the world
In-house and private practice counsel say UK judges have raised the bar for preliminary injunction requests
Interviews; Exclusives

Interviews; Exclusives

Dagg tells Managing IP about being starstruck when dealing with Nobel Prize-winning inventors, and how she deals with self-doubt
Phyllis Turner-Brim talks about her career, the need for balance in intellectual property policy and her passion for diversity and inclusion
Derek Gilliland, who became a magistrate judge at the Western District of Texas this month, delves into his work, thoughts on Alan Albright and ambitions
Kirupa Pushparaj talks about his move to a fintech start-up focused on young-person financial independence, career progression and start-up IP needs
Sources from the High Tech Inventors Alliance, the Senate Judiciary IP Subcommittee and NPE Dominion Harbor weigh in on the rise of the Western District of Texas
Heath Hoglund, chief patent counsel at Dolby in San Francisco, sits down with Managing IP to talk about licensing, FRAND and more
David Simon, senior vice president of IP at Salesforce, shares his views on Section 101, Fintiv, the DMCA, and more
The intellectual property CEO of one of the world's largest telecoms companies talks about licensing, harvesting collaboration and global outreach
In Managing IP’s first corner office podcast, Bryan Zielinski talks about his company’s IP challenges and opportunities, AI, and more
The Federal Circuit’s latest decision that Teva induced infringement has stakeholders worried that US skinny label law has been thrown out the window
In this Managing IP masterclass, IP directors from Thyssenkrupp and AB InBev discuss the challenges of managing a post-pandemic in-house team
ad ros bottom lb